John Stansel
Stock Analyst at JP Morgan
(1.12)
# 3,823
Out of 5,242 analysts
14
Total ratings
42.86%
Success rate
-5.87%
Average return
Main Sectors:
Stocks Rated by John Stansel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Neutral | $45 → $41 | $57.80 | -29.07% | 5 | Mar 19, 2026 | |
| HSIC Henry Schein | Maintains: Overweight | $78 → $92 | $72.55 | +26.82% | 2 | Feb 25, 2026 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $23 → $26 | $16.45 | +58.05% | 2 | Feb 5, 2026 | |
| MOH Molina Healthcare | Maintains: Neutral | $272 → $184 | $179.11 | +2.73% | 2 | Jul 29, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $148 → $149 | $192.23 | -22.49% | 1 | Nov 17, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $259 → $261 | $253.53 | +2.95% | 1 | Nov 17, 2023 | |
| ONON On Holding AG | Initiates: Buy | $31 | $38.01 | -18.44% | 1 | Apr 19, 2022 |
Centene
Mar 19, 2026
Maintains: Neutral
Price Target: $45 → $41
Current: $57.80
Upside: -29.07%
Henry Schein
Feb 25, 2026
Maintains: Overweight
Price Target: $78 → $92
Current: $72.55
Upside: +26.82%
Alignment Healthcare
Feb 5, 2026
Maintains: Overweight
Price Target: $23 → $26
Current: $16.45
Upside: +58.05%
Molina Healthcare
Jul 29, 2025
Maintains: Neutral
Price Target: $272 → $184
Current: $179.11
Upside: +2.73%
Quest Diagnostics
Nov 17, 2023
Maintains: Neutral
Price Target: $148 → $149
Current: $192.23
Upside: -22.49%
Labcorp Holdings
Nov 17, 2023
Maintains: Overweight
Price Target: $259 → $261
Current: $253.53
Upside: +2.95%
On Holding AG
Apr 19, 2022
Initiates: Buy
Price Target: $31
Current: $38.01
Upside: -18.44%